International Rett Syndrome Foundation   Report issue

Foundation Phase 2
Founded: Cincinnati OH United States (1999)

Organization Overview

First Clinical Trial
2010
NCT01253317
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

International Rett Syndrome Foundation Rettsyndrome.org

Active Ingredients

Drugs in Phase 2 Trials (3)

blarcamesine (1 trial)

mecasermin (Increlex) (2 trials)

nnz2566 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rett Syndrome (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 3